Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
7/24/2024 | $83.00 → $69.00 | Buy → Hold | Jefferies | |
7/18/2024 | $646.00 → $530.00 | Buy → Neutral | BofA Securities | |
6/26/2024 | $392.00 | Overweight | Piper Sandler | |
6/26/2024 | $400.00 | Overweight | Piper Sandler | |
6/24/2024 | $374.00 | Equal-Weight | Morgan Stanley | |
6/24/2024 | $643.00 | Overweight | Morgan Stanley | |
5/30/2024 | $405.00 | Outperform | Robert W. Baird | |
5/30/2024 | $649.00 | Outperform | Robert W. Baird |
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G - Elevance Health, Inc. (0001156039) (Subject)
4 - HUMANA INC (0000049071) (Issuer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
144 - Cigna Group (0001739940) (Subject)
8-K - CENTENE CORP (0001071739) (Filer)
ST. LOUIS, Aug. 15, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today that it has appointed Thomas R. Greco to the Centene Board of Directors, effective Aug. 9, 2024. Mr. Greco's term will run through the Company's 2025 annual meeting of stockholders. The appointment of Mr. Greco expands Centene's Board of Directors to 11 members. Mr. Greco is a seasoned operator and executive who brings more than four decades of public company leadership and expertise to Centene. Over the course of his career, he has implemented growth strategies and fostered
TAMPA, Fla., July 31, 2024 /PRNewswire/ -- Big Brothers Big Sisters of America (BBBSA), the nation's preeminent one-to-one youth mentoring organization, today announced the election of its newest Board member, Centene Corporation [Centene] (NYSE:CNC) Executive Vice President (EVP) of External Affairs, Jonathan Dinesman. Centene, a leading healthcare enterprise focused on transforming the health of the communities it serves, has been a long-time partner of BBBSA. Dinesman oversees Federal and State Government Relations; Centene's political action committee; Public Policy; Strat
Performant Financial Corporation (NASDAQ:PFMT) (Performant), primarily operating as Performant Healthcare Solutions, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, is proud to announce the appointment of Dr. Shantanu Agrawal, M.D. to its Board of Directors. Dr. Agrawal brings a wealth of expertise and experience in healthcare policy and payment integrity. As Chief Health Officer at Elevance Health (NYSE:ELV), Dr. Agrawal oversees the whole health strategy, including medical policy and clinical quality, as well as the community health strategy and Elevance Health Foundation. Prior to Elevance Health, Dr. Agrawal held numerous execut
ST. LOUIS, Aug. 29, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it will present at the 2024 Wells Fargo Healthcare Conference. Centene will present on Wednesday, September 4 at 8:45 a.m. Eastern Daylight Time (EDT). A simultaneous live audio webcast will be available at: https://event.webcasts.com/starthere.jsp?ei=1683335&tp_key=ee7495a9c5&tp_special=8. A webcast replay will be available following the presentation on Centene's website, www.centene.com, under the Investors section. About Centene CorporationCentene Corporation, a Fortune 500 company, is a leading healthcare enterprise t
Humana Inc. (NYSE:HUM), a leading health and well-being company, announced a new value-based kidney care program with Evergreen Nephrology designed to advance quality of care and help optimize health outcomes for people living with chronic kidney disease and end-stage kidney disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240829112855/en/ Humana Medicare Advantage members who qualify for the program will now have access to a team of Evergreen professionals who work together in partnership with their nephrologist to provide individualized, whole-person care. Evergreen has nephrology practice partnerships in the following
With Second Pharmacy Relocation This Year, AcariaHealth Emphasizes Commitment to Enhancing Patient Care, Empowering Employees, and Engaging Community DETROIT, Aug. 28, 2024 /PRNewswire/ -- AcariaHealth, a national specialty pharmacy focused on improving care and outcomes for patients living with complex medical conditions and a Centene company (NYSE:CNC), announced the relocation of its Homescripts pharmacy, a national leader in free goods service supporting patient medication access and adherence, to Shelby Township, Michigan. This new, nearly 33,000 square foot Detroit-area facility will provide ample space for business and pharmacy operations.
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on October 25, 2024 to stockholders of record as of the close of business on September 30, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, mil
Total revenues for the second quarter 2024 increased 25% to $60.5 billionShareholders' net income for the second quarter 2024 was $1.5 billion, or $5.45 per shareAdjusted income from operations1 for the second quarter 2024 was $1.9 billion, or $6.72 per share2024 outlook2 for adjusted income from operations1,2 is at least $28.40 per shareBLOOMFIELD, Conn., Aug. 1, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong second quarter 2024 results reflecting broad-based revenue and earnings growth across its businesses. "Our second quarter results underscore the strength of our diversified portfolio. We continue to deliver innovative solutions to meet the e
Reports 2Q24 earnings per share (EPS) of $5.62 on a GAAP basis, Adjusted EPS of $6.96; reports YTD 2024 EPS of $11.74 on a GAAP basis, $14.19 on an Adjusted basis Revises FY 2024 EPS guidance to 'approximately $12.81' (previously 'approximately $13.93') on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent Raises 2024 individual Medicare Advantage annual membership growth by 75,000 to now anticipate annual growth of approximately 225,000, or 4.2 percent Publishes Letter from the CEO and prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 9:00
4 - Cigna Group (0001739940) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
3 - CENTENE CORP (0001071739) (Issuer)
Jefferies downgraded Centene from Buy to Hold and set a new price target of $69.00 from $83.00 previously
BofA Securities downgraded Elevance Health from Buy to Neutral and set a new price target of $530.00 from $646.00 previously
Piper Sandler initiated coverage of Humana with a rating of Overweight and set a new price target of $392.00
Cantor Fitzgerald analyst Sarah James reiterates Molina Healthcare (NYSE:MOH) with a Overweight and maintains $406 price target.
Builds On Ongoing Collaboration With Google Health To Develop Population Health Solutions And Address Healthcare Challenges